Fundraising Fox

TCG Labs

Venture capital

San Francisco · 2 people tracked

Also known as TCG LABS MANAGEMENT, LP

Fox Verdict
Sign up to see your fit

Investment thesis

TCG Labs Soleil pursues a venture-biotech model built in collaboration with The Column Group, combining dedicated capital with an evergreen, scientist-led R&D hub. It forms independent portfolio companies each focused on a single therapeutic asset, guiding them from ideation through clinical proof of concept and positioning them for strategic partnerships. The firm deploys capital, scientific leadership, and operational infrastructure to advance both internally originated and externally acquired programs, as illustrated by its acquisition and clinical development of a KLK2-directed T-cell engager for metastatic prostate cancer through its portfolio company Juri Biosciences.

Invests inBiotechHealthtechMedical DevicesChinaSan FranciscoSouth San FranciscoUnited States

Source: firm website, verified Aug 7, 2026.

HQ
San Francisco, US
Instruments
Equity
Private fund assets
$846M
VC funds
2
Tracked investments
2

Team · 2 people

from the firm's website
Lucinda Y. Quan· Chief Operating Officer

Chief Operating Officer of TCG Labs Soleil, listed as investor contact.

Investments · 2 tracked

founders shown can be your intro path
Juri Biosciences

TCG Labs Soleil portfolio company developing a KLK2-directed T-cell engager for metastatic prostate cancer under a worldwide license from EpimAb.

Frequently asked questions

What sectors does TCG Labs focus on?
TCG Labs focuses on Biotech, Healthtech, Medical Devices.
Where is TCG Labs located?
TCG Labs is headquartered in San Francisco, US.

Images

TCG Labs photo

Similar investors

Featured in lists